Radiopharm Theranostics Limited Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
Radiopharm Theranostics Limited (RDPTF) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of $8955224.00 per share as of 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2025-09-18
- 2025-06-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $8955224.00.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2025-06-30 | $8955224.00 20-F · filed 2025-09-18 |